Royal Bank of Canada’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
4,133
+755
+22% +$234K ﹤0.01% 3408
2025
Q4
$995K Sell
3,378
-578
-15% -$108K ﹤0.01% 3652
2025
Q3
$209K Sell
3,956
-18,637
-82% -$904K ﹤0.01% 5070
2025
Q2
$950K Buy
22,593
+22,485
+20,819% +$856K ﹤0.01% 3936
2025
Q1
$4K Sell
108
-406
-79% -$25.4K ﹤0.01% 6422
2024
Q4
$39K Sell
514
-1,464
-74% -$106K ﹤0.01% 5814
2024
Q3
$113K Buy
1,978
+356
+22% +$19.2K ﹤0.01% 5261
2024
Q2
$67K Buy
+1,622
New +$76.7K ﹤0.01% 5511
2024
Q1
Sell
-1,157
Closed -$26K 7463
2023
Q4
$26K Buy
+1,157
New +$20.8K ﹤0.01% 6227
2023
Q2
Sell
-178
Closed -$2K 7562
2023
Q1
$2K Sell
178
-141
-44% -$5.95K ﹤0.01% 6790
2022
Q4
$11K Buy
319
+282
+762% +$8.79K ﹤0.01% 6514
2022
Q3
$1K Buy
37
+23
+164% +$1.15K ﹤0.01% 7244
2022
Q2
$1K Sell
14
-122
-90% -$13K ﹤0.01% 7178
2022
Q1
$21K Sell
136
-308
-69% -$63.3K ﹤0.01% 6582
2021
Q4
$132K Buy
444
+203
+84% +$59.5K ﹤0.01% 5725
2021
Q3
$67K Buy
241
+129
+115% +$35K ﹤0.01% 5985
2021
Q2
$31K Buy
112
+54
+93% +$19.3K ﹤0.01% 6324
2021
Q1
$28K Buy
58
+39
+205% +$27.7K ﹤0.01% 6230
2020
Q4
$16K Buy
+19
New +$11.1K ﹤0.01% 6166

Other funds holding PRAX

Royal Bank of Canada's PRAX Position: Q1 2026 in Review

Royal Bank of Canada increased its Praxis Precision Medicines (PRAX) stake by 22% in Q1 2026, buying an estimated $234K and bringing the position to 4,133 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #3408.

Royal Bank of Canada first reported a position in PRAX in Q4 2020 and has held it in 19 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Royal Bank of Canada held 4,133 shares of Praxis Precision Medicines worth $1.33M as of Q1 2026.
  • Royal Bank of Canada bought 755 Praxis Precision Medicines shares in Q1 2026, an estimated $234K.
  • Praxis Precision Medicines made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3408 holding.
  • Royal Bank of Canada first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 19 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.